1,7-Naphthyridin-8-amine - CAS 17965-82-1
Catalog: |
BB058811 |
Product Name: |
1,7-Naphthyridin-8-amine |
CAS: |
17965-82-1 |
Synonyms: |
8-Amino-1,7-naphthyridine |
IUPAC Name: | 1,7-naphthyridin-8-amine |
Description: | 1,7-Naphthyridin-8-amine is a useful chemical in organic synthesis. |
Molecular Weight: | 145.16 |
Molecular Formula: | C8H7N3 |
Canonical SMILES: | C1=CC2=C(C(=NC=C2)N)N=C1 |
InChI: | InChI=1S/C8H7N3/c9-8-7-6(3-5-11-8)2-1-4-10-7/h1-5H,(H2,9,11) |
InChI Key: | LRKLTZGZHDEBME-UHFFFAOYSA-N |
References: | Hu, Shuanghua, et al. Bioorg. & Med. Chem., 22(5), 1782-1790 (2014);Sun, Wei, et al. Bioorg. & Med. Chem. Let., 25(4), 803-806 (2015);Engers, Darren W., et al. ACS Chem. Neurosci., 7(9), 1192-1200 (2016). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2021246140-A1 | Modulators of metabotropic glutamate receptor 2 | 20200131 |
WO-2021155196-A1 | Modulators of metabotropic glutamate receptor 2 | 20200131 |
US-2021174983-A1 | Compositions for the filling of high aspect ratio vertical interconnect access (via) holes | 20191204 |
WO-2021112933-A1 | Compositions for the filling of high aspect ratio vertical interconnect access (via) holes | 20191204 |
KR-20210062778-A | Condensed compound and organic light-emitting device including the same | 20191121 |
WO-2020132459-A1 | Quinolinyl-pyrazine-carboxamide compounds and uses thereof | 20181220 |
US-2022081412-A1 | Quinolinyl-pyrazine-carboxamide compounds and uses thereof | 20181220 |
KR-20200058443-A | Heteroaryl compounds as CXCR4 inhibitors, compositions and methods of use | 20170925 |
WO-2019060860-A1 | HETEROARYL COMPOUNDS AS INHIBITORS OF CXCR4, COMPOSITION AND METHOD OF USE THEREOF | 20170925 |
EP-3687540-A1 | Heteroaryl compounds as cxcr4 inhibitors, composition and method using the same | 20170925 |
PMID | Publication Date | Title | Journal |
4189 | 19760401 | Towards rational therapy with monoamine oxidase inhibitors | The British journal of psychiatry : the journal of mental science |
3823 | 19760101 | On the influence of prostaglandin F2alpha-induced labor at term on the metabolism and coagulation of mother and fetus | Prostaglandins |
Complexity: | 137 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 145.063997236 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 145.063997236 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 51.8Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
-
(3R,4R,5S)-Methyl 5-Acetoxy-4-((methylsulfonyl)oxy)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
-
(3R,4R,5S)-Methyl 5-Acetoxy-4-hydroxy-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
-
[24177-07-9]
(2R,5S,10aS,10bS)-Octahydro-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid
-
(2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid
-
[31431-28-4]
(4-Amino-3-nitrophenyl)(4-methylphenyl)-methanone
-
[299409-58-8]
(4R)-2,2-Dimethyl-4-[(1S)-1-[(phenylmethyl)amino]-2-propen-1-yl]-3-oxazolidinecarboxylic Acid 1,1-Dimethylethyl Ester
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS